Revenue: The sum of all revenue fields included for a company's operating activities.
InMed Pharmaceuticals Inc. (INM) had Revenue of $4.60M for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
|
Revenue |
$4.60M |
$-7.68M |
|
$3.50M |
|
$1.10M |
|
$12.73M |
|
$-8.13M |
|
$0.47M |
|
$-7.67M |
|
$-7.67M |
|
$-7.68M |
|
$-7.68M |
|
$-7.68M |
|
$-7.68M |
|
$-8.13M |
|
$-7.91M |
|
0.38M |
|
0.38M |
|
$-20.20 |
|
$-20.20 |
|
| Balance Sheet Financials | |
$8.69M |
|
$1.25M |
|
$3.13M |
|
$11.82M |
|
$1.97M |
|
$0.64M |
|
$0.64M |
|
$2.62M |
|
$9.21M |
|
$7.42M |
|
$9.21M |
|
0.45M |
|
| Cash Flow Statement Financials | |
$-6.99M |
|
$-0.01M |
|
$4.65M |
|
$8.91M |
|
$6.57M |
|
$-2.34M |
|
$0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.41 |
|
-- |
|
-- |
|
0.07 |
|
0.10 |
|
23.94% |
|
-176.92% |
|
-176.92% |
|
-172.15% |
|
-166.79% |
|
-166.94% |
|
$-7.00M |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
2.81 |
|
13.03 |
|
28.01 |
|
-83.37% |
|
-103.40% |
|
-64.92% |
|
-77.92% |
|
$20.64 |
|
$-18.36 |
|
$-18.33 |
|